FMC Corp Q4 2025 Earnings Call Highlights: Declining Sales, Strategic Review, and Debt Reduction Targets

FMC Corp reported Q4 2025 sales of $1.08 billion, an 11% decline YoY. Adjusted EBITDA was $280 million, a 17% decline, and adjusted EPS was $1.20, a 33% decline. The company aims to reduce debt by $1 billion through asset sales and licensing agreements. FMC Corp expects a 5% decline in full-year sales for 2026 and is focusing on improving the competitiveness of its core portfolio and driving growth of new active ingredients.